Genetic testing before certain meds in hospital or clinic
This trial checks if genetic testing can help doctors pick safer drugs for you when you are in the hospital or visiting a clinic. If you qualify, you will give a cheek swab and be followed for about 12 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are about to start a specific drug that is part of this study.
- You can give a cheek swab for genetic testing.
- You live in the NHS Greater Glasgow and Clyde health board area.
- You can be followed for at least 12 weeks.
- You have not taken the study drug in the last 3 months (if starting as an outpatient).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using genetic information in the emergency department can help choose safer medications for patients 40 and older. It focuses on people who frequently visit the ER and are starting a new long-term medication.
This study tests whether a cheek-swab DNA test can help doctors choose safer medicines for you. If you are starting a new drug in primary care, you might join to help prevent side effects.
This trial tests whether a pharmacist review of your medications, plus information from a pharmacogenomic (PGx) test (which looks at how your genes affect your response to drugs), can help improve your medication plan. If you qualify, you'll get a free PGx test and a personalized medication review.
This trial tests whether a pharmacist can use your genetic information to better manage your depression medications. It may help find the right drug or dose for you.
This study tests if using genetic information can help doctors choose the right mental health medication or dose. It may help find treatments that work better with fewer side effects.
This study looks at whether a person’s genetic makeup can help choose safer medicines or improve how well treatment works. You may be asked for testing if you’ve had a bad reaction or treatment failure, or if you’re starting a new medicine that is known to be affected by genetics.
Hear when a new Pharmacogenomic Drug Interaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.